Skip to main content
. 2018 Oct 5;8:14896. doi: 10.1038/s41598-018-33190-8

Figure 1.

Figure 1

Establishment of afatinib- and osimertinib-resistant PC-9 and HCC-827 cells. (a) PC-9-afatinib-resistant cell line (PC-9-AR); PC-9-osimertinib-resistant cell line (PC-9-OR); HCC827-afatinib-resistant cell line (HCC827-AR); and HCC827-osimertinib-resistant cell line (HCC827-OR). The results of cell viability assays are shown. (b) Protein expression levels of EGFR signal pathway molecules.